The Latest Breaking News from Novo Nordisk

Here’s What Happened the Last Time Novo Nordisk Stock Was This Oversold

NVO stock is plunging lower in premarket trading after slashing its guidance for 2025 again.

Barchart · Jul 29, 2025

Trump’s 15% tariff on medicines will harm patients, say EU drugmakers

Trade group says levy will reduce access, disrupt supply chains and cut R&D

The Guardian - UK · Jul 29, 2025

Ozempic And Wegovy Maker Cuts Outlook In Surprise Move, Picks New CEO

Novo Nordisk A/S (NYSE:NVO), the Danish pharmaceutical giant renowned for its weight-loss drug Wegovy and diabetes treatment Ozempic, experienced a significant downturn on Tuesday following the company’s decision to trim its 2025 financial outlook.

Benzinga · Jul 29, 2025

Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'

As the Donald Trump administration plans up to 200% tariffs on pharmaceutical companies, Emily Field, head of European pharma research at Barclays, has said that it’s hard to predict which firm would be affected the most by these tariffs, except for Novo Nordisk A/S (NYSE:NVO).

Benzinga · Jul 16, 2025

Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback

Hims & Hers stock dipped after Novo Nordisk pulled back its partnership for a weight loss drug distribution, though that may not mean much.

MarketBeat · Jul 3, 2025

40 People Who Decided To Stun The Internet By Sharing Their Pics After Using Ozempic For Weight Loss

40 pictures showing how people looked before and after choosing Ozempic as a weight loss solution.

Bored Panda · Jul 2, 2025

Denmark and Sweden’s Øresund bridge turns 25: have the benefits run in both directions?

While Copenhagen’s fortunes grow alongside rise in Swedish commuters over 16km bridge, benefits for Malmö are proving less obvious

The Guardian - UK · Jun 28, 2025

‘Very obvious:’ Novo Nordisk may be illegally advertising Ozempic, says Spain’s health secretary

Spain is investigating Novo Nordisk over concerns it may be indirectly marketing its weight loss drugs. Euronews Health spoke to the country’s health secretary to find out more.

Euronews · Jun 27, 2025

What's Going On With Hims & Hers Health Stock Today?

Hims Hers Health Inc. (NYSE:HIMS) shares are trading higher Thursday. The stock appears to be bouncing back a bit after selling off to start the week. Here’s a look at what you need to know.

Benzinga · Jun 26, 2025

George Hincapie's new Modern Adventure team: Renaissance or more of the same? - Opinion

Has the spectre of Lance Armstrong's doping evaporated or will it come back to haunt the new squad?

Cycling News · Jun 26, 2025